These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2078420)

  • 1. In vitro inhibition of HIV-1 infectivity by human salivas.
    Archibald DW; Cole GA
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1425-32. PubMed ID: 2078420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregation of human immunodeficiency virus type 1 by human salivary secretions.
    Bergey EJ; Cho MI; Hammarskjöld ML; Rekosh D; Levine MJ; Blumberg BM; Epstein LG
    Crit Rev Oral Biol Med; 1993; 4(3-4):467-74. PubMed ID: 8373999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva.
    Bolscher JG; Nazmi K; Ran LJ; van Engelenburg FA; Schuitemaker H; Veerman EC; Nieuw Amerongen AV
    Eur J Oral Sci; 2002 Apr; 110(2):149-56. PubMed ID: 12013559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human submandibular saliva aggregates HIV.
    Malamud D; Davis C; Berthold P; Roth E; Friedman H
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):633-7. PubMed ID: 8396401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human submandibular saliva specifically inhibits HIV type 1.
    Nagashunmugam T; Friedman HM; Davis C; Kennedy S; Goldstein LT; Malamud D
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):371-6. PubMed ID: 9075477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV infectivity by human saliva.
    Malamud D; Nagashunmugam T; Davis C; Kennedy S; Abrams WR; Kream R; Friedman HM
    Oral Dis; 1997 May; 3 Suppl 1():S58-63. PubMed ID: 9456659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-infectivity activity of human salivary secretions toward human immunodeficiency virus.
    Robinovitch MR; Iversen JM; Resnick L
    Crit Rev Oral Biol Med; 1993; 4(3-4):455-9. PubMed ID: 8397002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus.
    Nagashunmugam T; Malamud D; Davis C; Abrams WR; Friedman HM
    J Infect Dis; 1998 Dec; 178(6):1635-41. PubMed ID: 9815215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of human salivas on recombinant HIV-1 proteins.
    Archibald DW; Hebert CA; Gregory KL; Lewis GK
    Crit Rev Oral Biol Med; 1993; 4(3-4):475-8. PubMed ID: 8374000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous salivary inhibitors of human immunodeficiency virus.
    Shugars DC; Alexander AL; Fu K; Freel SA
    Arch Oral Biol; 1999 Jun; 44(6):445-53. PubMed ID: 10401522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Submandibular salivary proteases: lack of a role in anti-HIV activity.
    Kennedy S; Davis C; Abrams WR; Billings PC; Nagashunmugam T; Friedman H; Malamud D
    J Dent Res; 1998 Jul; 77(7):1515-9. PubMed ID: 9663436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity.
    Robinovitch MR; Ashley RL; Iversen JM; Vigoren EM; Oppenheim FG; Lamkin M
    Oral Dis; 2001 Mar; 7(2):86-93. PubMed ID: 11355444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of herpes simplex virus type 1 replication by human salivary secretions.
    Bergey EJ; Gu M; Collins AR; Bradway SD; Levine MJ
    Oral Microbiol Immunol; 1993 Apr; 8(2):89-93. PubMed ID: 8395041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.
    Kazmi SH; Naglik JR; Sweet SP; Evans RW; O'Shea S; Banatvala JE; Challacombe SJ
    Clin Vaccine Immunol; 2006 Oct; 13(10):1111-8. PubMed ID: 16928883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple components contribute to ability of saliva to inhibit influenza viruses.
    White MR; Helmerhorst EJ; Ligtenberg A; Karpel M; Tecle T; Siqueira WL; Oppenheim FG; Hartshorn KL
    Oral Microbiol Immunol; 2009 Feb; 24(1):18-24. PubMed ID: 19121065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shear rate dependent viscoelastic behavior of human glandular salivas.
    van der Reijden WA; Veerman EC; Amerongen AV
    Biorheology; 1993; 30(2):141-52. PubMed ID: 8400152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.
    Habte HH; Mall AS; de Beer C; Lotz ZE; Kahn D
    Virol J; 2006 Nov; 3():99. PubMed ID: 17125499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies of salivary inhibition of HIV-1 infectivity.
    Yeh CK; Handelman B; Fox PC; Baum BJ
    J Acquir Immune Defic Syndr (1988); 1992; 5(9):898-903. PubMed ID: 1512690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of HIV-1 and human salivary mucins.
    Bergey EJ; Cho MI; Blumberg BM; Hammarskjöld ML; Rekosh D; Epstein LG; Levine MJ
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):995-1002. PubMed ID: 8083829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an enzyme-linked immunosorbent assay for determination of lysozyme in human parotid and submandibular-sublingual salivas.
    MacKay BJ; Goodman H; Cox D; Grossbard BL; Iacono VJ; Pollock JJ
    J Clin Microbiol; 1984 Jun; 19(6):844-8. PubMed ID: 6470098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.